Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMISULPRIDE vs AMIVANTAMAB-VMJW: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AMISULPRIDE vs AMIVANTAMAB-VMJW: Safety Overview

Metric AMISULPRIDE AMIVANTAMAB-VMJW
Total FAERS Reports 3,152 2,005
Deaths Reported 324 159
Death Rate 10.3% 7.9%
Hospitalizations 1,537 362
Average Patient Age 42.7 yrs 66.0 yrs
% Female Patients 41.3% 64.4%
FDA Approval Date Feb 26, 2020 N/A
Manufacturer Acacia Pharma Ltd N/A
Route INTRAVENOUS N/A
Marketing Status Prescription Prescription